Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Nexalin Technology (NXL) Cost of Revenue (2022 - 2025)

Historic Cost of Revenue for Nexalin Technology (NXL) over the last 4 years, with Q3 2025 value amounting to $3948.0.

  • Nexalin Technology's Cost of Revenue fell 6889.87% to $3948.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $47840.0, marking a year-over-year increase of 3936.15%. This contributed to the annual value of $36593.0 for FY2024, which is 4245.17% up from last year.
  • As of Q3 2025, Nexalin Technology's Cost of Revenue stood at $3948.0, which was down 6889.87% from $22838.0 recorded in Q2 2025.
  • Nexalin Technology's 5-year Cost of Revenue high stood at $187298.0 for Q3 2022, and its period low was $3948.0 during Q3 2025.
  • Moreover, its 4-year median value for Cost of Revenue was $9156.0 (2024), whereas its average is $31055.8.
  • As far as peak fluctuations go, Nexalin Technology's Cost of Revenue crashed by 9787.88% in 2023, and later surged by 21950.67% in 2024.
  • Quarter analysis of 4 years shows Nexalin Technology's Cost of Revenue stood at $6867.0 in 2022, then decreased by 23.82% to $5231.0 in 2023, then surged by 43.3% to $7496.0 in 2024, then crashed by 47.33% to $3948.0 in 2025.
  • Its Cost of Revenue stands at $3948.0 for Q3 2025, versus $22838.0 for Q2 2025 and $13558.0 for Q1 2025.